Author

B. McGee

Institution: Agios Pharmaceuticals (United States)

Observed institution: Agios Pharmaceuticals (United States)

OpenAlex ID: A5033574166

P1545: Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained Over Time in Patients With Pyruvate Kinase Deficiency Treated With Mitapivat in a Long-term Extension Study

2022 · R. F. Grace, A. Glenthøj, et al. · HemaSphere · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: